SEC Form 4 · accession 0001628280-17-002464
CHAMPIONS ONCOLOGY, INC. · CSBR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Philip P. Breitfeld
Director
Period of report
Jan 3, 2017
Accepted (ET)
Mar 10, 2017 · 11:03 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000771856
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase Common StockF1 | $1.59 | Jan 3, 2017 | A | 45,000 | A | — | Nov 1, 2021 | Common Stock | 45,000 | 45,000 | D |
Explanation of responses
- F1The Options will vest over a three-year period: upon completion of one full year of service, 1/3rd of the Option will be fully vested; upon completion of two full years of service, 2/3rds of the Option will be fully vested; upon completion of three full years of service, 100% of the Option will be fully vested.